Keyphrases
Multiple Myeloma
100%
Clinical Significance
100%
Abnormal Proteins
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
30%
Clinical Characteristics
20%
Overall Survival
20%
Medical Center
10%
Single Center
10%
Multivariate Analysis
10%
Prognostic Factors
10%
Multiple Myeloma Patients
10%
Creatinine
10%
Asan
10%
Confidence Interval
10%
Albumin
10%
Hazard Ratio
10%
Monoclonal Immunoglobulin
10%
Clonal Expansion
10%
Bone Marrow Cells
10%
Independent Prognostic Factor
10%
Median Overall Survival
10%
Survival Outcomes
10%
β2-microglobulin (β2-MG)
10%
Immunoglobulin Isotypes
10%
Clinical Survival
10%
Clinical Outcomes
10%
Working Diagnosis
10%
Biochemistry, Genetics and Molecular Biology
Overall Survival
100%
Autologous Stem Cell Transplantation
100%
Multivariate Analysis
33%
Microglobulin
33%
Intravenous Immunoglobulin
33%
Myeloma Protein
33%
Immunoglobulin A
33%
Immunoglobulin D
33%
Creatinine
33%
Albumin
33%
Immunology and Microbiology
Multiple Myeloma
100%
Overall Survival
60%
Autologous Stem Cell Transplantation
60%
Immunoglobulin A
20%
Bone Marrow Cell
20%
Immunoglobulin D
20%
Myeloma Protein
20%
Immunoglobulin Class
20%
Albumin
20%
Neuroscience
Stem Cell
100%
Creatinine
33%
Albumin
33%
Immunoglobulin Class
33%
Paraprotein
33%
Immunoglobulin A
33%
Immunoglobulin D
33%